Morbidity Table 31 provides an outline of all complications and the incidence of each complication type for all RNSH isolated valve surgery cases in 2021.
Discharge 30 day follow-up outcomes data was collected for each case (Figure 28). For 2021: • 47 (82.5%) patients were discharged home • 8 (14.0%) patients were discharged to a local or referring hospital • 2 (3.5%) hospital mortalities were reported
Complication
% of isolated valve
n
Return to theatre (RTT) total
11
19.3
Re-op bleeding / tamponade
2
3.5
Re-op deep sternal wound infection
2
1.8
Re-op insertion of pacemaker/AICD
7
12.3
Re-op other cardiac
2
3.5
Re-op other non-cardiac
4
7.0
New renal insufficiency
5
8.8
Pre-/post-operative MI
2
3.5
Cardiac inotrope or vasopressor use
37
64.9
>4 hours post-operatively
37
64.9
for low cardiac output syndrome
18
31.6
for low SVR syndrome
24
42.1
New cardiac arrhythmia
24
42.1
New neurologic
1
1.8
Stroke permanent
1
0.6
New pulmonary
14
24.6
Figure 20. Discharge location for isolated valve cases
Ventilation prolonged (>24 hrs)
8
14.0
Pneumonia
6
10.5
New infection
5
8.8
Deep sternal wound
1
1.8
Superficial access wound infection
2
3.5
Septicaemia
2
3.5
New other
6
10.5
Anticoagulant complications
2
3.5
Gastrointestinal tract complications
1
1.8
Multi-system failure
3
5.3
Table 31. Complications observed in isolated valve cases
46
47
Cardiac Surgery Annual Report 2021
Cardiac Surgery Annual Report 2021
Made with FlippingBook - professional solution for displaying marketing and sales documents online